RIS Article 179: The Nine Baseline Documents for Mexican Registration

1. Key takeaways

Article 179 of the Reglamento de Insumos para la Salud (RIS) sets out the application documentation for sanitary inputs manufactured in Mexico, and it enumerates nine items: the application made on the official form; scientific and technical information demonstrating that the product complies with the safety and efficacy characteristics it is claimed to possess; the draft labelling prepared in Spanish in accordance with the applicable standard; the instructions for use or operation, also in Spanish; a description of the manufacturing process; a description of the structure, materials, components and functions, applicable to medical devices; the certificate of good manufacturing practice; laboratory testing that verifies the product specifications; bibliographic references; and any other content that the Ministry of Health prescribes in the corresponding standard. Each of the nine items must be present and legible in the dossier, because the reviewing authority works through the list item by item when it assesses whether a submission can be admitted for substantive review.

• Application on the official form, together with scientific and technical information on safety and efficacy.
• Draft labelling in Spanish and instructions for use in Spanish.
• Manufacturing process description, and a separate description of structure, materials, components and functions.
• GMP certificate, laboratory testing of specifications, bibliographic references, and any additional content prescribed in the applicable standard.

2. Legal basis

The nine-item list is anchored in Article 179 of the RIS as amended by the amendment order published in the Diario Oficial de la Federacion on 24 April 2026. Article 180 adds the separate set of four documents for foreign-manufactured products, and Article 153 governs the use of the official application form. Two official standards sit directly behind specific items of the list: NOM-137-SSA1-2025, published in the Diario Oficial de la Federacion on 19 May 2026, is the standard on which the draft labelling must be based, and NOM-241-SSA1-2025, published on 4 April 2025, is the current standard underpinning the good manufacturing practice certificate. The table below consolidates these sources.

3. Expert insights

Insight 1: two of the nine items explicitly require Spanish. The draft labelling (item II) and the instructions for use or operation (item III) must be prepared in Spanish. These are the two items that foreign companies most often treat as content that can be supplied later, whereas in reality they are admission requirements for the dossier. An English-language version submitted as a placeholder does not discharge the obligation, and building the Spanish versions into the preparation schedule from the outset avoids a predictable round of corrections after filing.

Insight 2: item IX is an open catch-all. The provision lists as one item the other content that the Ministry of Health prescribes in the corresponding standard, which means that a NOM can introduce additional documentation requirements into the dossier. Once the 2025 edition of NOM-137 entered into force, new labelling-related requirements reach the dossier through this channel. Applicants should therefore treat the nine-item list as a floor rather than a ceiling, and monitor standard updates as part of dossier maintenance rather than as a one-off filing task.

Insight 3: items V and VI are frequently merged, and should not be. The description of the manufacturing process (item V) and the description of the structure, materials, components and functions (item VI, applicable to medical devices) are two independent items of content. In the dossier they should be written up as separate chapters rather than compressed into a single combined section. Keeping them apart mirrors the structure of the regulation, allows the reviewer to locate each item against its corresponding provision, and reduces the risk that a reviewer asks for the missing half of a merged section.

Insight 4: the GMP certificate under item VII points to the current standard. NOM-241 was revised in 2025, and the standard version to which the certificate corresponds must be updated in step with it. A certificate that cites the previous edition of the standard may attract a request for correction after the dossier has been admitted. Checking the standard citation on the face of the certificate, and confirming with the issuing body that the certificate was granted under the current edition, is a low-cost step that prevents a slow and avoidable deficiency cycle.

Insight 5: foreign manufacturers are bound by Article 179 as well. The wording of Article 180 states that its documents are required in addition to the previous documents, which means the nine items of Article 179 apply equally to foreign-manufactured products. The complete list for a foreign company is therefore nine items plus four items: the baseline dossier under Article 179, and the additional annexes under Article 180 described in the companion article of this series. Planning the dossier around the combined list, rather than around either list alone, is the correct reading of the two provisions together.

4. Practical recommendations

• Organise the dossier index in the order of the nine items of Article 179 so that reviewers can map each chapter directly to the provision.
• Prepare the draft labelling and the instructions for use in Spanish early in the project, and do not submit an English version as a substitute.
• Write the manufacturing process description and the structure and materials description as separate chapters, each accompanied by its own list of figures and tables.
• Check the standard cited on the GMP certificate and update it to NOM-241-SSA1-2025 before filing.
• Leave room in the dossier structure for the catch-all of item IX, and track NOM updates for documentation requirements that enter through it.

5. Verification checklist

• □ The dossier index follows the order of the nine items of Article 179.
• □ The official form is the current version.
• □ The draft labelling and instructions for use are in Spanish.
• □ The process description and the structure and materials description are written as separate chapters.
• □ The GMP certificate corresponds to NOM-241-SSA1-2025.
• □ Space has been reserved for additional content entering through item IX.

Legal information verified as of 28 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Mexican market. Our team manages COFEPRIS registrations and equivalence (equivalencia) reviews, coordinates third-party authorised centre routes, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com